Repligen | RGEN - 净收入



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.28B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


净收入 更改 日
Agilent USD 339M 34M 2026-03
Align Technology USD 108.29M 4.48M 2026-06
Bio Techne USD 51.05M 13.04M 2026-03
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Bruker USD -62.9M 66.4M 2026-06
Charles River Laboratories USD -1.48M 13.36M 2026-06
Danaher USD 870M 159M 2026-06
Dentsply International USD 37M 47M 2026-06
General Electric Aerospace USD 2.37B 466M 2026-06
Henry Schein USD 94M 13M 2026-06
Illumina USD 207M 73M 2026-06
IQVIA Holdings USD 256M 18M 2026-06
Mettler Toledo International USD 232.9M 63.44M 2026-06
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Pfizer USD -248M 2.94B 2026-06
Repligen USD 5.01M 3.32M 2026-06
Revvity USD 51.82M 11.1M 2026-06
Standard Biotools USD 127.07M 107.78M 2026-03
Thermo Fisher Scientific USD 1.74B 85M 2026-06
Waters USD -136M 64M 2026-06
West Pharmaceutical Services USD 154M 15.2M 2026-06